Strategy & Leadership

5 Unusual Startups That Will Blow Your Mind

Weird, wonderful and winning.

Updated

January 8, 2026 6:33 PM

A group of entrepreneurs coming up with different ideas. PHOTO: FREEPIK

If startup success stories usually make you picture cutting-edge tech, you might be missing a big part of the picture. Sometimes, the weirdest ideas shine the brightest, making real money and delighting both founders and customers. From ordinary rocks turned into pets to renting live chickens, these unusual startups show how far creativity and a pinch of humor can go.  

If you think the business world is all suits and serious pitches, think again—welcome to the wonderfully weird side of entrepreneurship.

1. Pet Rock: The low-maintenance pet
A small nest of straw cradles a hand-painted pet rock in the middle. PHOTO: PET ROCK

Owning a pet is a joy, but let’s be honest—it’s also a handful. Between shedding fur, endless feeding schedules, surprise messes and finding a sitter when you’re away, pet parenting is not exactly effortless.  

Back in 1975, an advertising executive named Gary Dahl found himself joking about this very problem over drinks with friends. His solution for the “perfect” pet: a rock. No feeding, no walking, no grooming and absolutely no accidents on the carpet.

What started as a joke quickly snowballed into a real business. Smooth stones were sourced from Rosarito Beach in Mexico, then packed in playful cardboard “pet carrier” boxes with little air holes and a bed of straw. To make the experience even more cheeky, every Pet Rock came with a care manual that instructed owners to give their new companion sunlight, affection and, of course, a name.

It was absurd and hilarious, but it worked. Selling at US$3.95 apiece in the ’70s, Pet Rocks became a cultural phenomenon. Today, you can still find them on Amazon, but they will now set you back around US$29.99 or more. Would you bring home a Pet Rock? People in the ’70s sure did.

2. Rent The Chicken: Bringing fresh eggs home
A small flock of chickens on a grass field. PHOTO: UNSPLASH

Back in 2013, Phil and Jenn Tompkins a couple duo, launched the company "Rent The Chicken" with one straightforward goal: give people a chance to try raising backyard hens and enjoy fresh eggs without the long-term commitment.  

Through partnerships with local farmers across the U.S. and Canada, this backyard chicken rental startup brings egg-laying hens straight to people’s yards. It offers different rental packages, but a standard six-month rental costs around US$500. This usually includes two hens ready to lay within days, a portable coop, feed, food and water dishes and expert support for any chicken-related questions.

The chickens arrive in spring and stay until fall. When the season ends, families can choose to return the hens, extend the rental or even buy them for about US$40 each at the end of the contract.

Today, the company works with partners in 29 states, from Oregon to Texas, and in parts of Canadain p. For people outside those areas, an out-of-area purchase package that comes with three hens can be shipped anywhere in the 48 contiguous states in the U.S. for about US$1,550.

In a way, it’s a fun and hands-on path to food security — giving families the joy of collecting their own eggs and knowing exactly where their breakfast comes from.

3. I Want to Draw a Cat For You: Personalized purr-fect artwork
Colorful cat cartoons in a playful, simple drawing. PHOTO: I WANT TO DRAW A CAT FOR YOU

By day, Gadlin worked as a full-time web developer for a television broadcasting company. Outside of work, he poured his energy into comedy and writing. That creative streak took him back to high school days, when he had drawn silly cats for a comic series called Silly Cats Comic.

With those doodles as his foundation and a bit of basic design know-how, Gadlin launched his website, “I Want to Draw a Cat For You” in 2011. The concept was as simple as it was funny: visitors would describe the cat of their dreams and Gadlin would personally hand-draw it, then send it their way.  

This quirky startup idea landed him on Shark Tank, where he secured an offer of US$25,000 from investor Mark Cuban for a 33% stake in the business. Not bad for stick-figure cats.

When the site first launched, customers could pay extra US$5 for colour. Shipping cost US$1 if they didn’t mind the drawing arriving in a folded envelope, or US$5 for a flat mailer. For delivery within 48 hours, there was a US$19.95 rush fee that many customers were happy to pay.  

These days, Gadlin leans more on digital delivery and limited runs of his cat drawings at US$50, rather than mailing every single piece of his art. What he once described as “mediocre cat drawings” has become proof that a simple, original idea can claw its way into the startup world.

4. Rent-A-Friend: Friendly companionship for hire
Friends taking selfies at a lively outdoor get-together. PHOTO: UNSPLASH

Imagine arriving in a new city with no one to show you around. That is exactly the kind of situation where RentAFriend can help.  

Launched in 2009 by Scott Rosenbaum, the unusual business was inspired by Japan’s “rental family” services, where people can hire a friend, a date or even a parent for a short period. Rosenbaum saw an opportunity to adapt that concept for North America, but with a focus strictly on platonic friendship.

Here’s how it works: Anyone can sign up as a “friend” for free by creating a profile, listing their interests and setting an hourly rate. People who want to hire pay a membership fee, typically around US$24.95 a month, to connect with friends across the platform.  

With a rented friend, you can do pretty much anything platonic. Go sightseeing, hit a museum, catch a game, work out together or even bring them along to a party or family event. At its heart, RentAFriend connects people who need company with those happy to earn a little extra simply by being one.

5. Entomo Farms: Farming crickets for protein
At Entomo Farm, roasted crickets sit alongside cardboard boxes built for sustainable cricket farming. PHOTO: ENTOMO FARMS

Back in 2014, in the small town of Norwood, Ontario, Canada, three brothers—Jarrod, Darren and Ryan Goldin, set out to do something that sounded downright bizarre at the time: farm crickets for people to eat.

The idea first struck Jarrod after he saw a cricket-based nutrition bar on television. Around the same time, the UN released a report on edible insects as a sustainable food source. Suddenly, the “weird” idea didn’t seem so weird after all.

At Entomo Farms, crickets are raised in cage-free “cricket condos”, where they live in warm, dark spaces that mimic their natural habitat. They’re fed and cared for until they reach about six or seven weeks old, then humanely harvested using a CO₂ method. From there, they’re rinsed, roasted and ground into a fine powder—no additives, just pure cricket protein.

The appeal goes beyond novelty. Crickets are packed with nutrients and need far less land, feed and water than beef, making them both healthy and eco-friendly.

While their approach may seem unconventional, what drives Entomo Farms is simple: making sustainable, responsible food accessible to everyone.

Final thoughts

These startups prove that innovation doesn’t always wear a serious face. Sometimes, it turns up wrapped in humor, curiosity or even a touch of absurdity, yet still manages to spark real change. From crickets turned into protein to chickens rented out by the season, each weird startup idea shows that entrepreneurship thrives when people dare to think differently.

While some of these unusual business ideas burned bright then faded, others are still evolving in the background, shifting from fads to niche services or steady, quiet companies. What they share is a willingness to test an idea most people would dismiss at first glance.

That is the real takeaway for founders. Weird startup ideas will not always scale into unicorns, yet they can test new consumer habits, open up fresh markets and shape culture in surprising ways. If you are building something new, there is space for products that make people laugh, think or raise an eyebrow before they reach for their wallet.

Keep Reading

Hong Kong

Hong Kong AI Biotech Startup METiS TechBio Draws Major Investor Demand in IPO

METiS TechBio’s blockbuster IPO signals rising investor interest in AI startups focused on how drugs are delivered inside the body

Updated

May 14, 2026 3:02 PM

HIV-1 virus particles, coloured red. PHOTO: UNSPLASH

Investors are beginning to place bigger bets on AI startups focused on drug delivery infrastructure rather than drug discovery alone. That shift was on display this week after METiS TechBio, a Hong Kong tech-bio startup focused on AI-powered drug delivery systems, debuted on the Hong Kong Stock Exchange.

The listing made METiS TechBio the world’s first publicly traded AI-powered drug delivery startup and the first AI-powered large-molecule biopharmaceutical startup listed in Hong Kong. The startup raised more than HKD 2.1 billion through its IPO, making it the largest healthcare listing in Hong Kong so far in 2026.

Investor demand was unusually strong. The Hong Kong public offering was oversubscribed by more than 6,900 times while the international tranche recorded 82 times oversubscription. More than 280 institutional investors participated in the international placing.

The strong demand reflects a wider shift in AI biotech. Over the past few years, much of the sector’s attention has focused on using AI to discover new drugs or molecules. METiS is taking a different approach. The startup focuses on how medicines are delivered inside the body after they are developed.

That challenge is becoming harder to ignore in biotech. Designing a therapy is only one part of the process. Delivering it precisely to specific organs, tissues or cells remains a major hurdle, especially for newer therapies involving RNA, proteins and large-molecule drugs.

METiS is trying to solve that problem through its proprietary NanoForge platform. The system uses AI to design and test nanodelivery systems that help medicines reach targeted areas inside the body more efficiently. The platform combines AI models, simulation systems and high-throughput screening tools to speed up formulation development and improve delivery precision.

The startup says it has already achieved targeted delivery across eight organs and tissue systems including the liver, lungs, heart, muscles and central nervous system.

One of its lead programs, MTS-004, became China’s first AI-enabled formulation drug to complete a Phase III clinical trial. The drug is being developed for pseudobulbar affect, a neurological condition that affects emotional expression. According to the startup, AI tools helped reduce preclinical formulation development time from up to two years to less than three months.

Investor interest in the IPO also came from some of the world’s largest asset managers and healthcare funds. BlackRock led the cornerstone investments with a USD 50 million subscription. Other participating investors included UBS Asset Management Singapore, Mirae Asset, ORIX Corporation, Deerfield, RTW, Hillhouse Capital and IDG Capital.

METiS is also building what it describes as a “platform collaboration + product partnership” business model. The startup currently works with more than 30 pharmaceutical and biotechnology partners globally, including large pharmaceutical companies and medical research institutions.

The company reported RMB 105 million in revenue in 2025, largely tied to upfront payments connected to its MTS-004 partnership agreements. It also said some platform collaboration contracts could reach milestone values of up to USD 109 million.

Chris Lai said: "The future of biomedicine will no longer be simply about 'taking medicine when one falls ill.' METiS TechBio's ambition is to harness AI to build nano-rockets that can navigate with precision through the inner space of the human body's 30 trillion cells, write the code of nucleic acids and proteins into cells, and reprogram diseased and aging cells into healthy cells. This was our founding aspiration, and it is the mission to which we will dedicate our lives. The IPO marks a new starting point for us to accelerate forward, and we will strive to live up to the support and trust we have received from all sectors."

The IPO also highlights how Hong Kong is increasingly positioning itself as a hub for next-generation biotech and AI healthcare startups. While investor excitement around AI drug discovery has cooled in parts of the market, startups focused on delivery systems and biotech infrastructure are beginning to attract stronger institutional backing.

For METiS, the challenge now will be turning that investor confidence into commercially viable therapies and long-term partnerships. But the listing suggests that AI-driven drug delivery is starting to emerge as a category investors are willing to treat as core biotech infrastructure rather than a niche research experiment.